Preliminar evaluation of cytokines in the hepatitis C-schistosomiasis co-infection
AUTOR(ES)
Morais, Clarice NL, Carvalho, Bruno M, Melo, Wlademir G, Lopes, Edmundo PA, Domingues, Ana Lúcia C, Jucá, Norma T, Souza, Wayner, Abath, Frederico GC, Montenegro, Silvia ML
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2006-10
RESUMO
Evaluation of hepatic fibrosis is usually performed by histopathological examination of biopsies. However, this is an invasive and potentially dangerous procedure. Several studies have proposed serum biological markers of hepatic fibrosis. This communication evaluates the use of serum cytokines as markers of hepatic fibrosis in hepatitis C, schistosomiasis, and co-infection.
Documentos Relacionados
- Co-infection with hepatitis B virus and hepatitis C virus
- Co-infection with hepatitis C virus and human T lymphocyte virus
- Human immunodeficiency virus and hepatitis C virus/hepatitis B virus co-infection in Southern Brazil: clinical and epidemiological evaluation
- Visceral Leishmaniasis/HIV co-infection in northeast Brazil: evaluation of outcome
- Prevalence of human immunodeficiency virus/hepatitis C virus co-infection in Brazil and associated factors: a review